National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 3) (PB 40 of 2015)

Link to law: https://www.comlaw.gov.au/Details/F2015L00590

 
PB 40 of 2015
National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 3)
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 22 April 2015
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 3).
            (2)        This Instrument may also be cited as PB 40 of 2015.
2          Commencement
            This Instrument commences on 1 May 2015.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
(a)   omit from the column headed “Determined Price”:             1.45        substitute:             1.21
(b)   omit from the column headed “Claimed Price”:                  5.92        substitute:             4.94
[2] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
(a)   omit from the column headed “Determined Price”:             2.54        substitute:             2.12
(b)   omit from the column headed “Claimed Price”:                  9.16        substitute:             7.64
[3] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
(a)   omit from the column headed “Determined Price”:             0.72        substitute:             0.62
(b)   omit from the column headed “Claimed Price”:                  3.44        substitute:             2.96
[4] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
(a)   omit from the column headed “Determined Price”:             1.43        substitute:             1.24
(b)   omit from the column headed “Claimed Price”:                  4.28        substitute:             3.71
[5] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             0.64        substitute:             0.55
(b)   omit from the column headed “Claimed Price”:                  3.35        substitute:             2.88
[6] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
(a)   omit from the column headed “Determined Price”:             0.92        substitute:             0.80
(b)   omit from the column headed “Claimed Price”:                  3.68        substitute:             3.20
[7] Schedule 1, entry for Amoxycillin in the form Tablet 1 g (as trihydrate)
(a)   omit from the column headed “Determined Price”:             1.47        substitute:             1.27
(b)   omit from the column headed “Claimed Price”:                  1.86        substitute:             1.61
[8] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin
(as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
(a)   omit from the column headed “Determined Price”:             1.26        substitute:             1.11
(b)   omit from the column headed “Claimed Price”:                  3.90        substitute:             3.44
[9] Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin
(as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
(a)   omit from the column headed “Determined Price”:             1.80        substitute:             1.59
(b)   omit from the column headed “Claimed Price”:                  5.51        substitute:             4.87
[10]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
(a)   omit from the column headed “Determined Price”:             2.06        substitute:             1.81
(b)   omit from the column headed “Claimed Price”:                  5.75        substitute:             5.05
[11]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
(a)   omit from the column headed “Determined Price”:             2.93        substitute:             2.58
(b)   omit from the column headed “Claimed Price”:                  7.63        substitute:             6.72
[12]         Schedule 1, entry for Atenolol
(a)   omit from the column headed “Determined Price”:             1.32        substitute:             1.06
(b)   omit from the column headed “Claimed Price”:                  3.29        substitute:             2.64
[13]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg
(a)   omit from the column headed “Determined Price”:             16.56     substitute:             14.01
(b)   omit from the column headed “Claimed Price”:                  18.99     substitute:             16.07
[14]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg
(a)   omit from the column headed “Determined Price”:             20.69     substitute:             17.51
(b)   omit from the column headed “Claimed Price”:                  23.12     substitute:             19.57
[15]         Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg
(a)   omit from the column headed “Determined Price”:             25.87     substitute:             21.89
(b)   omit from the column headed “Claimed Price”:                  28.36     substitute:             24.00
[16]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg
(a)   omit from the column headed “Determined Price”:             1.40        substitute:             1.11
(b)   omit from the column headed “Claimed Price”:                  3.02        substitute:             2.39
[17]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg
(a)   omit from the column headed “Determined Price”:             4.19        substitute:             3.30
(b)   omit from the column headed “Claimed Price”:                  5.81        substitute:             4.58
[18]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg
(a)   omit from the column headed “Determined Price”:             12.54     substitute:             9.88
(b)   omit from the column headed “Claimed Price”:                  14.16     substitute:             11.16
[19]         Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg
(a)   omit from the column headed “Determined Price”:             15.16     substitute:             11.94
(b)   omit from the column headed “Claimed Price”:                  16.78     substitute:             13.22
[20]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 20]
(a)   omit from the column headed “Determined Price”:             20.22     substitute:             17.01
(b)   omit from the column headed “Claimed Price”:                  22.19     substitute:             18.67
[21]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity: 50]
omit from the column headed “Claimed Price”:          51.50     substitute:             43.32
[22]         Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg
(a)   omit from the column headed “Determined Price”:             78.74     substitute:             66.25
(b)   omit from the column headed “Claimed Price”:                  79.54     substitute:             66.92
[23]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
(a)   omit from the column headed “Determined Price”:             1.76        substitute:             1.56
(b)   omit from the column headed “Claimed Price”:                  2.41        substitute:             2.14
[24]         Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
(a)   omit from the column headed “Determined Price”:             2.45        substitute:             2.17
(b)   omit from the column headed “Claimed Price”:                  3.75        substitute:             3.32
[25]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Doryx; Pricing Quantity/Pack Quantity: 7]
(a)   omit from the column headed “Determined Price”:             1.03        substitute:             0.88
(b)   omit from the column headed “Claimed Price”:                  2.93        substitute:             2.50
[26]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline; Pricing Quantity/Pack Quantity: 7]
(a)   omit from the column headed “Determined Price”:             1.03        substitute:             0.88
(b)   omit from the column headed “Claimed Price”:                  1.83        substitute:             1.56
[27]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Doryx; Pricing Quantity/Pack Quantity: 21]
omit from the column headed “Claimed Price”:          7.54        substitute:             6.44
[28]         Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline; Pricing Quantity/Pack Quantity: 21]
omit from the column headed “Claimed Price”:          4.91        substitute:             4.20
[29]         Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) [Brand: Doryx]
(a)   omit from the column headed “Determined Price”:             1.83        substitute:             1.57
(b)   omit from the column headed “Claimed Price”:                  5.01        substitute:             4.30
[30]         Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
[Brand: Mayne Pharma Doxycycline]
(a)   omit from the column headed “Determined Price”:             1.83        substitute:             1.57
(b)   omit from the column headed “Claimed Price”:                  3.15        substitute:             2.70
[31]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
(a)   omit from the column headed “Determined Price”:             4.28        substitute:             3.74
(b)   omit from the column headed “Claimed Price”:                  8.04        substitute:             7.03
[32]         Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
(a)   omit from the column headed “Determined Price”:             5.45        substitute:             4.76
(b)   omit from the column headed “Claimed Price”:                  9.21        substitute:             8.04
[33]         Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
(a)   omit from the column headed “Determined Price”:             4.72        substitute:             3.40
(b)   omit from the column headed “Claimed Price”:                  9.53        substitute:             6.86
[34]         Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
(a)   omit from the column headed “Determined Price”:             4.76        substitute:             3.43
(b)   omit from the column headed “Claimed Price”:                  10.31     substitute:             7.43
[35]         Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
(a)   omit from the column headed “Determined Price”:             3.44        substitute:             3.00
(b)   omit from the column headed “Claimed Price”:                  6.00        substitute:             5.23
[36]         Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
(a)   omit from the column headed “Determined Price”:             4.95        substitute:             4.32
(b)   omit from the column headed “Claimed Price”:                  7.50        substitute:             6.55
[37]         Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
(a)   omit from the column headed “Determined Price”:             8.96        substitute:             7.82
(b)   omit from the column headed “Claimed Price”:                  11.52     substitute:             10.05
[38]         Schedule 1, entry for Fluoxetine in the form Capsule 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             5.22        substitute:             4.52
(b)   omit from the column headed “Claimed Price”:                  6.88        substitute:             5.96
[39]         Schedule 1, entry for Fluoxetine in the form Tablet, dispersible, 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             5.22        substitute:             4.52
(b)   omit from the column headed “Claimed Price”:                  6.88        substitute:             5.96
[40]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg
(a)   omit from the column headed “Determined Price”:             6.71        substitute:             5.97
(b)   omit from the column headed “Claimed Price”:                  9.53        substitute:             8.48
[41]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg
(a)   omit from the column headed “Determined Price”:             10.17     substitute:             9.05
(b)   omit from the column headed “Claimed Price”:                  12.99     substitute:             11.56
[42]         Schedule 1, entry for Frusemide in the form Tablet 20 mg
(a)   omit from the column headed “Determined Price”:             0.71        substitute:             0.62
(b)   omit from the column headed “Claimed Price”:                  1.49        substitute:             1.30
[43]         Schedule 1, entry for Frusemide in the form Tablet 40 mg
(a)   omit from the column headed “Determined Price”:             1.29        substitute:             1.13
(b)   omit from the column headed “Claimed Price”:                  3.25        substitute:             2.85
[44]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Imdur Durule]
(a)   omit from the column headed “Determined Price”:             3.58        substitute:             3.22
(b)   omit from the column headed “Claimed Price”:                  6.31        substitute:             5.68
[45]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Brand: Monodur 60 mg]
(a)   omit from the column headed “Determined Price”:             3.58        substitute:             3.22
(b)   omit from the column headed “Claimed Price”:                  5.58        substitute:             5.02
[46]         Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)
(a)   omit from the column headed “Determined Price”:             8.47        substitute:             7.61
(b)   omit from the column headed “Claimed Price”:                  11.20     substitute:             10.06
[47]         Schedule 1, entry for Lamotrigine in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             4.23        substitute:             3.60
(b)   omit from the column headed “Claimed Price”:                  6.11        substitute:             5.20
[48]         Schedule 1, entry for Lamotrigine in the form Tablet 25 mg
(a)   omit from the column headed “Determined Price”:             9.42        substitute:             8.02
(b)   omit from the column headed “Claimed Price”:                  12.16     substitute:             10.35
[49]         Schedule 1, entry for Lamotrigine in the form Tablet 50 mg
(a)   omit from the column headed “Determined Price”:             15.71     substitute:             13.38
(b)   omit from the column headed “Claimed Price”:                  18.14     substitute:             15.45
[50]         Schedule 1, entry for Lamotrigine in the form Tablet 100 mg
(a)   omit from the column headed “Determined Price”:             26.17     substitute:             22.28
(b)   omit from the column headed “Claimed Price”:                  28.70     substitute:             24.44
[51]         Schedule 1, entry for Lamotrigine in the form Tablet 200 mg
(a)   omit from the column headed “Determined Price”:             43.97     substitute:             37.44
(b)   omit from the column headed “Claimed Price”:                  46.51     substitute:             39.60
[52]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
(a)   omit from the column headed “Determined Price”:             2.90        substitute:             2.47
(b)   omit from the column headed “Claimed Price”:                  5.73        substitute:             4.88
[53]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
(a)   omit from the column headed “Determined Price”:             4.84        substitute:             4.12
(b)   omit from the column headed “Claimed Price”:                  7.66        substitute:             6.52
[54]         Schedule 1, entry for Lisinopril in the form Tablet 5 mg
(a)   omit from the column headed “Determined Price”:             3.06        substitute:             2.62
(b)   omit from the column headed “Claimed Price”:                  5.72        substitute:             4.90
[55]         Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Privinil 10]
(a)   omit from the column headed “Determined Price”:             4.58        substitute:             3.92
(b)   omit from the column headed “Claimed Price”:                  7.61        substitute:             6.51
[56]         Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Brand: Zestril]
(a)   omit from the column headed “Determined Price”:             4.58        substitute:             3.92
(b)   omit from the column headed “Claimed Price”:                  7.23        substitute:             6.19
[57]         Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Privinil 20]
(a)   omit from the column headed “Determined Price”:             5.78        substitute:             4.94
(b)   omit from the column headed “Claimed Price”:                  8.81        substitute:             7.53
[58]         Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Brand: Zestril]
(a)   omit from the column headed “Determined Price”:             5.78        substitute:             4.94
(b)   omit from the column headed “Claimed Price”:                  8.45        substitute:             7.22
[59]         Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg
(a)   omit from the column headed “Determined Price”:             4.38        substitute:             3.65
(b)   omit from the column headed “Claimed Price”:                  6.41        substitute:             5.34
[60]         Schedule 1, entry for Meloxicam in the form Capsule 15 mg
(a)   omit from the column headed “Determined Price”:             6.39        substitute:             5.33
(b)   omit from the column headed “Claimed Price”:                  8.41        substitute:             7.01
[61]         Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
(a)   omit from the column headed “Determined Price”:             4.38        substitute:             3.65
(b)   omit from the column headed “Claimed Price”:                  6.41        substitute:             5.34
[62]         Schedule 1, entry for Meloxicam in the form Tablet 15 mg
(a)   omit from the column headed “Determined Price”:             6.39        substitute:             5.33
(b)   omit from the column headed “Claimed Price”:                  8.41        substitute:             7.01
[63]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
(a)   omit from the column headed “Determined Price”:             3.16        substitute:             2.79
(b)   omit from the column headed “Claimed Price”:                  5.47        substitute:             4.83
[64]         Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg
(a)   omit from the column headed “Determined Price”:             5.06        substitute:             4.47
(b)   omit from the column headed “Claimed Price”:                  7.37        substitute:             6.51
[65]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]
(a)   omit from the column headed “Determined Price”:             3.16        substitute:             2.79
(b)   omit from the column headed “Claimed Price”:                  5.47        substitute:             4.83
[66]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Glucophage]
(a)   omit from the column headed “Determined Price”:             3.16        substitute:             2.79
(b)   omit from the column headed “Claimed Price”:                  3.68        substitute:             3.25
[67]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
(a)   omit from the column headed “Determined Price”:             5.51        substitute:             4.86
(b)   omit from the column headed “Claimed Price”:                  7.81        substitute:             6.89
[68]         Schedule 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 1 g
(a)   omit from the column headed “Determined Price”:             5.06        substitute:             4.47
(b)   omit from the column headed “Claimed Price”:                  7.37        substitute:             6.51
[69]         Schedule 1, entry for Methylprednisolone
(a)   omit from the column headed “Determined Price”:             13.91     substitute:             10.24
(b)   omit from the column headed “Claimed Price”:                  15.09     substitute:             11.11
[70]         Schedule 1, omit entry for Mianserin
[71]         Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             6.42        substitute:             5.49
(b)   omit from the column headed “Claimed Price”:                  7.39        substitute:             6.32
[72]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
(a)   omit from the column headed “Determined Price”:             5.58        substitute:             4.78
(b)   omit from the column headed “Claimed Price”:                  8.41        substitute:             7.20
[73]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             8.56        substitute:             7.32
(b)   omit from the column headed “Claimed Price”:                  9.52        substitute:             8.14
[74]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
(a)   omit from the column headed “Determined Price”:             9.31        substitute:             7.96
(b)   omit from the column headed “Claimed Price”:                  12.14     substitute:             10.38
[75]         Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
(a)   omit from the column headed “Determined Price”:             12.90     substitute:             11.03
(b)   omit from the column headed “Claimed Price”:                  13.87     substitute:             11.86
[76]         Schedule 1, entry for Moclobemide in the form Tablet 150 mg
(a)   omit from the column headed “Determined Price”:             5.77        substitute:             5.16
(b)   omit from the column headed “Claimed Price”:                  6.11        substitute:             5.46
[77]         Schedule 1, entry for Moclobemide in the form Tablet 300 mg
(a)   omit from the column headed “Determined Price”:             11.11     substitute:             9.93
(b)   omit from the column headed “Claimed Price”:                  11.78     substitute:             10.53
[78]         Schedule 1, entry for Omeprazole
(a)   omit from the column headed “Determined Price”:             6.78        substitute:             5.48
(b)   omit from the column headed “Claimed Price”:                  9.25        substitute:             7.48
 
[79]         Schedule 1, entry for Perindopril [Brands: Coversyl 2.5mg; PREXUM 2.5]
(a)   omit from the column headed “Determined Price”:             2.74        substitute:             2.33
(b)   omit from the column headed “Claimed Price”:                  4.32        substitute:             3.67
[80]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 10 mg
(a)   omit from the column headed “Determined Price”:             2.40        substitute:             2.00
(b)   omit from the column headed “Claimed Price”:                  3.74        substitute:             3.12
[81]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 20 mg
(a)   omit from the column headed “Determined Price”:             3.81        substitute:             3.17
(b)   omit from the column headed “Claimed Price”:                  5.14        substitute:             4.28
[82]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 40 mg
(a)   omit from the column headed “Determined Price”:             5.94        substitute:             4.93
(b)   omit from the column headed “Claimed Price”:                  7.36        substitute:             6.11
[83]         Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium 80 mg
(a)   omit from the column headed “Determined Price”:             9.13        substitute:             7.58
(b)   omit from the column headed “Claimed Price”:                  10.55     substitute:             8.76
[84]         Schedule 1, entry for Prochlorperazine
(a)   omit from the column headed “Determined Price”:             1.31        substitute:             1.15
(b)   omit from the column headed “Claimed Price”:                  3.80        substitute:             3.34
[85]         Schedule 1, entry for Quinapril in the form Tablet 5 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             3.27        substitute:             2.91
(b)   omit from the column headed “Claimed Price”:                  4.45        substitute:             3.96
[86]         Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             4.68        substitute:             4.16
(b)   omit from the column headed “Claimed Price”:                  5.86        substitute:             5.21
[87]         Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             5.78        substitute:             5.14
(b)   omit from the column headed “Claimed Price”:                  6.96        substitute:             6.19
[88]         Schedule 1, entry for Ranitidine in each of the forms: Tablet 150 mg (as hydrochloride); and Tablet 300 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             5.24        substitute:             4.33
(b)   omit from the column headed “Claimed Price”:                  6.37        substitute:             5.26
[89]         Schedule 1, entry for Sertraline in each of the forms: Tablet 50 mg (as hydrochloride); and Tablet 100 mg (as hydrochloride)
(a)   omit from the column headed “Determined Price”:             2.75        substitute:             2.26
(b)   omit from the column headed “Claimed Price”:                  3.32        substitute:             2.73
[90]         Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg
(a)   omit from the column headed “Determined Price”:             3.85        substitute:             3.41
(b)   omit from the column headed “Claimed Price”:                  6.88        substitute:             6.09
[91]         Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg
(a)   omit from the column headed “Determined Price”:             8.27        substitute:             7.32
(b)   omit from the column headed “Claimed Price”:                  11.31     substitute:             10.01
[92]         Schedule 1, entry for Sumatriptan in each of the forms: Tablet 50 mg (as succinate); and Tablet (fast disintegrating) 50 mg
(as succinate)
(a)   omit from the column headed “Determined Price”:             3.86        substitute:             3.22
(b)   omit from the column headed “Claimed Price”:                  4.86        substitute:             4.05
[93]         Schedule 1, entry for Tamoxifen
(a)   omit from the column headed “Determined Price”:             12.24     substitute:             10.53
(b)   omit from the column headed “Claimed Price”:                  13.12     substitute:             11.29
[94]         Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
(a)   omit from the column headed “Determined Price”:             1.09        substitute:             0.93
(b)   omit from the column headed “Claimed Price”:                  3.04        substitute:             2.59
[95]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
(a)   omit from the column headed “Determined Price”:             2.96        substitute:             2.53
(b)   omit from the column headed “Claimed Price”:                  6.59        substitute:             5.63
[96]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
(a)   omit from the column headed “Determined Price”:             3.98        substitute:             3.40
(b)   omit from the column headed “Claimed Price”:                  8.32        substitute:             7.11
[97]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
(a)   omit from the column headed “Determined Price”:             4.85        substitute:             4.14
(b)   omit from the column headed “Claimed Price”:                  9.77        substitute:             8.34
[98]         Schedule 1, entry for Trandolapril in the form Capsule 500 micrograms
(a)   omit from the column headed “Determined Price”:             1.57        substitute:             1.39
(b)   omit from the column headed “Claimed Price”:                  4.40        substitute:             3.90
[99]         Schedule 1, entry for Trandolapril in the form Capsule 1 mg
(a)   omit from the column headed “Determined Price”:             4.16        substitute:             3.69
(b)   omit from the column headed “Claimed Price”:                  6.98        substitute:             6.19
[100]       Schedule 1, entry for Trandolapril in the form Capsule 2 mg
(a)   omit from the column headed “Determined Price”:             5.02        substitute:             4.45
(b)   omit from the column headed “Claimed Price”:                  7.85        substitute:             6.96
[101]       Schedule 1, entry for Trandolapril in the form Capsule 4 mg
(a)   omit from the column headed “Determined Price”:             9.42        substitute:             8.36
(b)   omit from the column headed “Claimed Price”:                  12.25     substitute:             10.87
[102]       Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
(a)   omit from the column headed “Determined Price”:             7.56        substitute:             6.40
(b)   omit from the column headed “Claimed Price”:                  8.37        substitute:             7.09
[103]       Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
(a)   omit from the column headed “Determined Price”:             14.96     substitute:             12.67
(b)   omit from the column headed “Claimed Price”:                  15.89     substitute:             13.46
Read Entire Law on www.comlaw.gov.au